The novel monoclonal antibody HPC2 and N-cadherin distinguish pancreatic ductal adenocarcinoma from cholangiocarcinoma

Human Pathology

Volumn 43, Issue 10, 2012, Pages 1583-1589

  Hooper, Jody E ^a   Morgan, Terry K ^a   Grompe, Markus ^b,c   Sheppard, Brett C ^a,c   Troxell, Megan L ^a,c   Corless, Christopher L ^a,c   Streeter, Philip R ^b,c  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Cholangiocarcinoma; HPC2; N cadherin; Pancreatic ductal adenocarcinoma

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY HUMAN PANCREATIC CANCER FUSION 2; NERVE CELL ADHESION MOLECULE; TUMOR MARKER; UNCLASSIFIED DRUG;

AMPULLARY ADENOCARCINOMA; ARTICLE; BILE DUCT CARCINOMA; COLON ADENOCARCINOMA; GALLBLADDER ADENOCARCINOMA; GALLBLADDER CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; MAJOR CLINICAL STUDY; PANCREAS ADENOCARCINOMA; PROTEIN EXPRESSION;

ANTIBODIES, MONOCLONAL; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CADHERINS; CARCINOMA, PANCREATIC DUCTAL; CHOLANGIOCARCINOMA; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM PROTEINS; PANCREATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84866517142     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2011.11.012     Document Type: Article

References (18)

1. S.R. Alberts, G.J. Gores, and G.P. Kim Treatment options for hepatobiliary and pancreatic cancer Mayo Clin Proc 82 2007 628 637 (Pubitemid 46709432)
2. P. Chu, E. Wu, and L.M. Weiss Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases Mod Pathol 13 2000 962 972
3. P.G. Chu, R.E. Schwarz, S.K. Lau, Y. Yen, and L.M. Weiss Immunohistochemical staining in the diagnosis of pancreaticobiliary and ampulla of Vater adenocarcinoma Am J Surg Pathol 29 2005 359 367 (Pubitemid 40321972)
4. S.A. Geller, D. Dhall, and R. Alsabeh Application of immunohistochemistry to liver and gastrointestinal neoplasms Arch Pathol Lab Med 132 2008 490 499 (Pubitemid 351328818)
5. S. Ligato, H. Zhao, D. Mandich, and R. Cartun KOC (K homology domain containing protein overexpressed in cancer) and S100A4-protein immunoreactivity improves the diagnostic sensitivity of biliary brushing cytology for diagnosing pancreaticobiliary malignancies Diagn Cytopath 36 2008 561 567
6. F. Lin, J. Shi, and H. Liu Diagnostic utility of S100P and von Hippel-Lindau gene product (pVHL) in pancreatic adenocarcinoma - with implication of their roles in early tumorigenesis Am J Surg Pathol 32 2008 78 91
7. R. Kozyraki, J.Y. Scoazec, and J.F. Flejou Expression of cadherins and beta-catenin in primary epithelial tumors of the liver Gastroenterology 110 1996 1137 1149 (Pubitemid 26113754)
8. H. Zhao, D. Mandich, R.W. Cartun, and S. Ligato Expression of K homology domain containing protein overexpressed in cancer in pancreatic FNA for diagnosing adenocarcinoma of pancreas Diagn Cytopath 35 2007 700 704 (Pubitemid 350035041)
9. R.K. Yantiss, B.A. Woda, and G.R. Fanger KOC (K homology domain containing protein overexpressed in cancer): a novel molecular marker that distinguishes between benign and malignant lesions of the pancreas Am J Surg Pathol 29 2005 188 195 (Pubitemid 40170636)
10. J.T. Ney, H. Zhou, and B. Sipos Podocalyxin-like protein 1 expression is useful to differentiate pancreatic ductal adenocarcinomas from adenocarcinomas of the biliary and gastrointestinal tracts Hum Pathol 38 2006 359 364 (Pubitemid 46096563)
11. E. Patsenker, L. Wilkens, and V. Banz The alpha-v-beta-6 integrin is a highly specific immunohistochemical marker for cholangiocarcinoma J Hepatol 52 2010 362 369
12. J.L. Hornick, G.Y. Lauwers, and R. Odze Immunohistochemistry can help distinguish metastatic pancreatic adenocarcinomas from bile duct adenomas and hamartomas of the liver Am J Surg Pathol 29 2005 381 389 (Pubitemid 40321975)
13. T. Shimonishi, K. Miyazaki, and Y. Nakanuma Cytokeratin profile relates to histological subtypes and intrahepatic location of intrahepatic cholangiocarcinoma and primary sites of metastatic adenocarcinoma of liver Histopathology 37 2000 55 63 (Pubitemid 30496736)
14. M.J. Kornstein, and J. Rosai CD5 labeling of thymic carcinomas and other nonlymphoid neoplasms Am J Clin Path 109 1998 722 726 (Pubitemid 28247271)
15. A. Somoracz, P. Tatrai, and G. Horvath Agrin immunohistochemistry facilitates the determination of primary versus metastatic origin of liver carcinomas Hum Pathol 41 2010 1310 1319
16. P.G. Chu, D.A. Arber, and L.M. Weiss Expression of T/NK-cell and plasma cell antigens in nonhematopoetic epithelioid neoplasms: an immunohistochemical study of 447 cases Anat Path 120 2003 64 70 (Pubitemid 37046371)
17. N. Abe, T. Watanabe, and Y. Izumisato High mobility group A1 is expressed in metastatic adenocarcinoma to the liver and intrahepatic cholangiocarcinoma, but not in hepatocellular carcinoma: its potential use in the diagnosis of liver neoplasms J Gastroent 38 2003 1144 1149 (Pubitemid 38128825)
18. J.F. Mosnier, C. Kandel, and D. Cazals-Hatem N-cadherin serves as diagnostic biomarker in intrahepatic and perihilar cholangiocarcinomas Mod Pathol 22 2009 182 190